James C Czirr - Net Worth and Insider Trading
James C Czirr Net Worth
The estimated net worth of James C Czirr is at least $17 Million dollars as of 2024-12-01. James C Czirr is the 10% Owner of Galectin Therapeutics Inc and owns about 5,922,207 shares of Galectin Therapeutics Inc (GALT) stock worth over $17 Million. Details can be seen in James C Czirr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James C Czirr has not made any transactions after 2024-04-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James C Czirr
James C Czirr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James C Czirr owns 2 companies in total, including Galectin Therapeutics Inc (GALT) , and Mitesco Inc (MITI) .
Click here to see the complete history of James C Czirr’s form 4 insider trades.
Insider Ownership Summary of James C Czirr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-04-23 | director |
| MITI | Mitesco Inc | 2017-02-07 | director |
James C Czirr Latest Holdings Summary
James C Czirr currently owns a total of 1 stock. James C Czirr owns 5,922,207 shares of Galectin Therapeutics Inc (GALT) as of April 23, 2024, with a value of $17 Million.
Latest Holdings of James C Czirr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-04-23 | 5,922,207 | 2.89 | 17,115,178 |
Holding Weightings of James C Czirr
James C Czirr Form 4 Trading Tracker
According to the SEC Form 4 filings, James C Czirr has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Galectin Therapeutics Inc is the sale of 25,000 shares on April 23, 2024, which brought James C Czirr around $76,500.
Insider Trading History of James C Czirr
- 1
James C Czirr Trading Performance
GuruFocus tracks the stock performance after each of James C Czirr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James C Czirr is 114.16%. GuruFocus also compares James C Czirr's trading performance to market benchmark return within the same time period. The performance of stocks bought by James C Czirr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James C Czirr's insider trading performs compared to the benchmark.
Performance of James C Czirr
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.51 | | | | | |
| Relative Return to S&P 500(%) | 20.78 | | | | | |
James C Czirr Ownership Network
James C Czirr Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
James C Czirr is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, James C Czirr made 1 insider transaction in Galectin Therapeutics Inc (GALT) with a net sale of 25,000. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 11,800 shares, with a net purchase of 11,800 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
James C Czirr Mailing Address
Above is the net worth, insider trading, and ownership report for James C Czirr. You might contact James C Czirr via mailing address: 4908 South Ashton Court, Spokane Wa 99223.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
